Divi’s Laboratories Limited

NSE : DIVISLAB BSE : 532488 ISIN CODE : INE361B01024 Industry : Pharmaceuticals & Drugs House : Divis Labs

 

Related News:

Divi’s Laboratories Q3 Results : Consolidated Profit rises 92 % to Rs 902 crore

Divis Laboratories hits a 52-week high:

Kiran S.Divi has been appointed as the CEO of Divis Laboratories Ltd

 

Company Overview:

Divi’s Laboratories Limited manufactures and sells generic active pharmaceutical ingredients (APIs), intermediates, and nutraceutical ingredients in India, the United States, Asia, Europe, and internationally. It also undertakes custom synthesis of APIs and intermediates; and supplies a range of carotenoids, as well as markets vitamins to nutritional, pharma, food/beverage, and feed industries. The company was formerly known as Divi’s Research Center and changed its name to Divi’s Laboratories Limited in 1994. Divi’s Laboratories Limited was incorporated in 1990 and is headquartered in Hyderabad, India.
Industry: Drug ManufacturersSpecialty & Generic
Sector: Healthcare
Phone: 91 40 2378 6300

Management:

Chairman Ramesh BV Nimmagadda
Managing Director Murali K Divi
Company Secretary M Satish Choudhury
Executive Director N V Ramana
Non Executive Independent Director G Suresh Kumar
R Ranga Rao
KVK Seshavataram
S Ganapaty
Sunaina Singh
K V Chowdary
Whole Time Director Kiran S Divi
Madhusudana Rao Divi
Whole Time Director – Commercial Nilima Prasad Divi